Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
Bangladesh
· Delayed Price · Currency is BDT 96.60
-5.40 (-5.29%)
At close: Mar 8, 2026
Beacon Pharmaceuticals Market Cap
Beacon Pharmaceuticals has a market cap or net worth of 23.10 billion as of March 9, 2026. Its market cap has decreased by -21.38% in one year.
Market Cap
23.10B
Enterprise Value
29.61B
Revenue
11.58B
Ranking
n/a
PE Ratio
40.52
Stock Price
96.60
Market Cap Chart
Since August 12, 2010, Beacon Pharmaceuticals's market cap has increased from 19.93B to 23.10B, an increase of 15.89%. That is a compound annual growth rate of 0.95%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The ACME Laboratories | 16.48B |
| Unilever Consumer Care | 41.50B |
| Renata | 49.23B |
| Beximco Pharmaceuticals PLC. | 51.21B |
| The IBN SINA Pharmaceutical Industry | 9.96B |
| Asiatic Laboratories | 7.75B |
| Orion Pharma | 7.00B |
| Navana Pharmaceuticals | 6.19B |